2026年，全球生物医药资本市场出现明显复苏。根据投资银行Locust ...

Biotech一级市场融资在今年3月迎来了久违的“小高峰”，总融资额超过了21亿美元。 这主要是由于两家明星公司分别获得了两笔大额融资：TYK2抑制剂同类最佳竞争者公司Alumis获得2.59亿美元C轮融资，以及Prometheus创始人再次创业成立的自免药物公司Mirador Therapeutics获得4亿美元A轮融资。

当AI深入药物研发，Biotech的组织与研发方式将如何改变？数据、知识与实验经验，又如何沉淀为可持续增值的资产？ 带着这些疑问，11月12日（周四）晚上19:30，写意直播间联手水木分子开启【泰州医博】系列直播，我们邀请Parkway ...

那一段悲惨的时间中，“闪崩”成了美国Biotech公司的常态，那些曾经被市场强烈看好的管线，只要临床数据欠佳，立刻就会引发投资者的抛售。1993年、1994年，两年中股价一夜腰斩的Biotech公司就不下十家。

So far in 2026, biotech deals amounted to $106 billion over 201 transactions, according to PitchBook data. That momentum in dealmaking comes despite an interest rate environment that has turned for ...

Biotech stocks saw a major rebound in 2025, with key indexes significantly outperforming the S&P 500. Private investment in longevity science doubled in 2024, highlighting growing interest in ...

Biotech Acquisition Company raised $230 million in its initial public offering in January 2021. BAC's Class A ordinary shares and warrants trade on the Nasdaq Capital Market under the symbols "BIOT" ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Ben McClure is a seasoned venture finance advisor with 10+ years of experience helping CEOs secure early-stage investments. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in ...

Could 2026 be the year that industry layoffs start to decline? (iStock/Getty Images Plus) Welcome to Fierce Biotech’s fifth annual layoff tracker, a resource designed to keep pace with the sector’s ...

Biotech ETFs diversify investment risks by pooling various biotech stocks. One of the top biotech ETFs, iShares Biotechnology ETF, reported a 7.29% average return since 2001. VanEck Biotech ETF offers ...